Join
Live feed
·
INSIDERFilingvia Quantisnow
Rani Therapeutics Holdings Inc. logo

Chief Technical Officer Javadi Alireza sold $301 worth of shares (386 units at $0.78) and covered exercise/tax liability with 309 shares, decreasing direct ownership by 7% to 9,380 units (SEC Form 4) (withholding obligation)

ByQuantisnow·Wall Street's wire, on your screen.
RANI· Rani Therapeutics Holdings Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RANI (Rani Therapeutics Holdings Inc.) and more on Quantisnow.